tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
MYGN is currently covered by 8 analysts with an average price target of $16.7. This is a potential upside of $3.2 (23.7%) from yesterday's end of day stock price of $13.5.
Myriad Genetics's activity chart (see below) currently has 137 price targets and 91 ratings on display. The stock rating distribution of MYGN is 50% BUY, 18.75% HOLD and 31.25% SELL.
Analysts average stock forecasts to be materialized ratio is 88.54% with an average time for these price targets to be met of 244 days.
Highest price target for MYGN is $34, Lowest price target is $20, average price target is $16.7.
Most recent stock forecast was given by PUNEET SOUDA from LEERINK on 09-Dec-2024. First documented stock forecast 24-Oct-2012.
3/26/09 2 for 1
9/12/00 2 for 1
Currently out of the existing stock ratings of MYGN, 8 are a BUY (50%), 3 are a HOLD (18.75%), 5 are a SELL (31.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$21
$7.58 (56.48%)
$35
24 days ago
(09-Dec-2024)
5/9 (55.56%)
$6.18 (41.70%)
169
Buy
$34
$20.58 (153.35%)
$29
4 months 20 days ago
(13-Aug-2024)
3/5 (60%)
$5.82 (20.65%)
112
Sell
$20
$6.58 (49.03%)
$14
4 months 26 days ago
(07-Aug-2024)
3/3 (100%)
$-6.64 (-24.92%)
165
Sell
$20
$6.58 (49.03%)
$19
6 months 30 days ago
(03-Jun-2024)
7/7 (100%)
$-2.35 (-10.51%)
194
Buy
$31
$17.58 (131.00%)
$28
11 months 4 days ago
(29-Jan-2024)
4/5 (80%)
$8.28 (36.44%)
227
What is MYGN (Myriad Genetics) average time for price targets to be met?
Which analyst has the current highest performing score on MYGN (Myriad Genetics) with a proven track record?
Which analyst has the most public recommendations on MYGN (Myriad Genetics)?
Which analyst is the currently most bullish on MYGN (Myriad Genetics)?
Which analyst is the currently most reserved on MYGN (Myriad Genetics)?
